We make a wide range of prescription medicines, vaccines and consumer healthcare products. Explore our three business area portfolios for more information. We list many – but not all – of our products on the following pages.
In March 2015 we completed a 3-part transaction with Novartis which reshaped our business.
We acquired Novartis’s vaccines business (excluding influenza vaccines) and combined our consumer healthcare businesses to create a new company.
In addition, Novartis acquired our marketed Oncology portfolio and the R&D activities related to it.
More about our products
Our prescription medicines
Our pharmaceuticals business discovers, develops and makes medicines to treat a broad range of the world's most common acute and chronic diseases.